strong trend continu robust top-line
growth underpin market share gain along gross
margin recoveri build price dissip cost
inflat mind reflect premium
strong fundament continu stock trade weak
consum tape despit strong result robust
organ sale growth consum guidanc rais
alreadi somewhat expect premium valuat price-to-earnings
call indic recent price increas proceed better
expect lower anticip volum elast report
consum domest volum declin volum would posit
exclud pullback oxiclean laundri price/mix also
sound confid price increas would remain place despit pullback
commod highlight input cost still prior cost
inflat occur multi-year period higher price help recent
gener greater system profit retailers/manufactur exampl
ration competit environ highlight arm hammer brand
gain bp laundri market share overal percentag
sale sold promot decreas bp competitor particularli
henkel remain ration valu tier addit gain bp
share cat litter dd sale growth categori decreas
promot neg side indic oxiclean brand declin
recov back half year oxiclean dark protect innov
launch given delay retail shelf reset also impact launch
arm hammer cloud control cat litter person care side
portfolio challeng area remain includ trojan condom
categori challeng less sexual activ low birth rate
altern form contracept although recent announc
condom price increas il critter kid gummi vitamin prolifer
competitor pressur market share spinbrush electron toothbrush
new competitor quip gain share overal
breadth top-line strength continu power brand
grow share us top categori grow categori growth
remain steadi around sound optimist growth becom
balanc household product person care balanc
year
household person unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
growth
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
number ep cent consensu
mse guidanc driven bp organ top-line
beat vs consensu augment gross margin beat lower lead
profit beat vs consensu organ sale
consensu chd guidanc report top-line bp
consensu gross margin came bp consensu bp yoy
price increas acquisit account connect flawless
acquisit product program partial off-set higher commod
bp yoy total sg decreas bp consensu drive
oper profit upsid versu consensu decreas bp yoy
bp forecast although rais guidanc
market depress flawless acquisit account spend shift
innov launch delay due later retail shelf
reset lower tax rate cent benefit vs model
yoy increas yoy
segment result total consum organ sale growth strong
spd drag total compani result continu weak
divis divis consum domest organ sale increas
lower volum posit price/mix ii consum
organ sale increas higher volum
favor price/mix iii spd organ sale decreas volum
reduc demand dairi industri due low milk price partial
off-set price
rais end ep guidanc rais low end ep
guidanc versu prior rang cent
prior consensu also increas organ sale guidanc
prior report sale growth expect prior call
rais consum domest segment organ sale growth guidanc
prior rais consum intern prior
lower spd flat slightli expect gross margin
expand bp y-o-i previous bp reflect lower inflat
impact acquisit market dollar expect increas market
sale expect flat vs bp prior continu
expect bp oper margin expans impli adjust sg
sale expect bp y-oy bp prior continu
expect cash oper comment releas
expect spend back organic/gross profit upsid brand build
 new product invest regard guid organ
sale growth report sale growth ep
consensu mse also reflect partial revers upsid
higher market typic conserv forward quarter
unchang ep estim beat leav ep
estim unchang cent prior consensu
price target also remain unchang base ep multipl
solid top-line growth skew
lower growth competit us market
price acceler market share
gain drive solid corpor growth
valuat reason chd valuat
ep
risk achiev price
sustain rang greater price
lower commod product higher
expect potenti accret
acquisit consolid
us promot intens key
categori ramp us volum downsid
commod inflat execut risk
deriv base case scenario
topline/gross margin upsid rebound laundri result drive bp
top-line upsid cost effici weaker expect commod inflat
drive increment basi point gross margin upsid bp
price upsid appli multipl deviat last
averag bull case ep
robust organ growth deliv average org sale growth
slightli long-term target appli price-to-earnings
base case ep standard deviat last
averag strong organ growth
secular us slowdown worsen revenu growth bp forecast
due competit price pressur us volum downsid spur
reinvest compress valuat deviat
last averag bear case ep
exhibit bear bull us environ risk laundri price
sale
sale
sale bp chang
sale
sale bp chang
sale
sale bp chang
equiti earn affili
incom minor interest tax
equiti invest affili
account payabl accru expens
postretir postemploy benefit
depreci amort
equiti earn affili
chang a/l
increas liabil
provid oper
flow invest activ
acquisit net
purchas new product line
addit ppe
invest distribut affili
proce sale fix asset
use invest activ
flow financ activit
purchas treasuri stock
proce exercis stock option etc
use financ activ
exchang rate effect
net increas decreas equiv
equiv beg
equiv end
